Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor.author | Frigotto, Katia Gleicielly | - |
Autor(es): dc.contributor.author | Garcia, Giovana Salviano Braga | - |
Autor(es): dc.contributor.author | Valviesse, Vitor Ribeiro Gomes de Almeida | - |
Autor(es): dc.contributor.author | Pires, Karina Lebeis | - |
Data de aceite: dc.date.accessioned | 2022-02-25T15:46:14Z | - |
Data de disponibilização: dc.date.available | 2022-02-25T15:46:14Z | - |
Data de envio: dc.date.issued | 2022-02-20 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/699366 | - |
Resumo: dc.description.abstract | Background: Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a side effect common to many drugs in cancer treatment. CIPN symptoms are mainly sensory, as paresthesia and pain, especially in body extremities. It can affect the patient's life, requiring a dose reduction or interruption of therapy, which can impact patient's survival. Methods: Twenty-one hematology outpatients who were treated by neurotoxic potential drugs were selected. The Douleur neuropathique 4 questionnaire was applied, a patient form was made for data collection, and the data obtained was analyzed. Main Results: The prevalence of CIPN was 47,62%. Five patients (23,81%) did not had signs of neurotoxicity, four (19,05%) patients were classified as Grade 1, seven (33,33% ) as Grade 2, and four (19,05%) as Grade 3, and one (4,76%) patient as Grade 4. Patients who had symptoms of CIPN had already received an average of 55,42% of the scheduled treatment. Three patients (14,29%) had to reduce the dose or change the drugs, and one patient (4,76%) had to discontinue it. Conclusion: This study support the hypothesis that CIPN is an important side effect in cancer treatments. Being a cause of reducing the dose or temporarily suspending it, which can affect the success of the treatment and patient’s survival. | pt_BR |
Idioma: dc.language.iso | en | pt_BR |
Palavras-chave: dc.subject | CLINICAL | pt_BR |
Título: dc.title | CLINICAL PREVALENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN ONCO-HEMATOLOGICAL PATIENTS (Atena Editora) | pt_BR |
Tipo de arquivo: dc.type | livro digital | pt_BR |
Aparece nas coleções: | Livros digitais |
Arquivos associados: | ||||
---|---|---|---|---|
CLINICAL.pdf | 334,55 kB | Adobe PDF | /bitstream/capes/699366/1/CLINICAL.pdfDownload |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: